Who owns PROCEPT BioRobotics Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PRCT from SEC Form 13F filings across 232 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 232 institutions disclosed 54.5M shares of PROCEPT BioRobotics Corp worth $994.9M — about 95.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
232
13F holders
$994.9M
value, 2026 filers
95.1%
of shares outstanding (54.5M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PRCT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.8M | $88.3M | 0.0% | 8.5% | -0.5% |
| 2 | T. Rowe Price Investment Management, Inc. | 3.3M | $59.7M | 0.0% | 5.7% | +0.3% |
| 3 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2.8M | $50.8M | 0.0% | 4.9% | -1.3% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | $44.9M | 0.0% | 4.3% | -2.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | $44.0M | 0.0% | 4.2% | -2.0% |
| 6 | JPMORGAN CHASE & CO | 1.9M | $34.8M | 0.0% | 3.3% | +580.8% |
| 7 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.9M | $33.8M | 0.4% | 3.2% | +69.8% |
| 8 | STATE STREET CORP | 1.7M | $30.9M | 0.0% | 3% | +4.8% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $24.3M | 0.0% | 2.3% | -10.1% |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.3M | $24.2M | 0.0% | 2.3% | -0.3% |
| 11 | Janus Henderson Group Ltd.NEW | 1.3M | $24.1M | 0.0% | 2.3% | new |
| 12 | LMR Partners LLP | 1.2M | $22.4M | 0.1% | 2.1% | +70.1% |
| 13 | MILLENNIUM MANAGEMENT LLC | 1.2M | $22.2M | 0.0% | 2.1% | +95.4% |
| 14 | BAILLIE GIFFORD & CO | 1.2M | $21.9M | 0.0% | 2.1% | +32.0% |
| 15 | Balyasny Asset Management L.P. | 1.0M | $19.1M | 0.0% | 1.8% | +3619.0% |
| 16 | MORGAN STANLEY | 968,614 | $17.6M | 0.0% | 1.7% | +60.0% |
| 17 | FEDERATED HERMES, INC. | 845,204 | $15.4M | 0.0% | 1.5% | -32.6% |
| 18 | BANK OF AMERICA CORP /DE/ | 841,856 | $15.3M | 0.0% | 1.5% | +63.1% |
| 19 | Trexquant Investment LP | 785,520 | $14.3M | 0.1% | 1.4% | +101.6% |
| 20 | Fiera Capital Corp | 763,953 | $13.9M | 0.1% | 1.3% | -1.4% |
| 21 | HRT FINANCIAL LP | 719,935 | $13.1M | 0.0% | 1.3% | +399.6% |
| 22 | GOLDMAN SACHS GROUP INC | 663,750 | $12.1M | 0.0% | 1.2% | +48.3% |
| 23 | Soleus Capital Management, L.P. | 600,358 | $10.9M | 0.4% | 1% | -40.1% |
| 24 | Champlain Investment Partners, LLC | 593,437 | $10.8M | 0.4% | 1% | -39.5% |
| 25 | NORTHERN TRUST CORP | 593,040 | $10.8M | 0.0% | 1% | -0.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.